InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,307.88
(
0.48%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.66
(
0.28%
)
Bitcoin
61,578.60
(
-0.05%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

xavierprivas

Send PM Follow Ignore
Followers 6
Posts 162
Boards Moderated 0
Alias Born 09/14/2009

xavierprivas

Re: n4807g post# 199301

Tuesday, 01/26/2016 9:14:20 PM

Tuesday, January 26, 2016 9:14:20 PM

Post# of 252412
It does not save any money compared to the autologous T-cells.
These allogeneic T-cells still come from a donor, it is not really off the
shelf like Cellectis, thus it is not a threat for Juno, Kite, etc.

I have no position in Cellectis because I think it has low probability for success IMO.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up